These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 23975340)
1. Cyclooxygenase-2 promotes hepatocellular apoptosis by interacting with TNF-α and IL-6 in the pathogenesis of nonalcoholic steatohepatitis in rats. Cheng Q; Li N; Chen M; Zheng J; Qian Z; Wang X; Huang C; Xu S; Shi G Dig Dis Sci; 2013 Oct; 58(10):2895-902. PubMed ID: 23975340 [TBL] [Abstract][Full Text] [Related]
2. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats. Chen J; Liu D; Bai Q; Song J; Guan J; Gao J; Liu B; Ma X; Du Y Mol Med Rep; 2011; 4(5):811-6. PubMed ID: 21643627 [TBL] [Abstract][Full Text] [Related]
3. Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression. Tian F; Zhang YJ; Li Y; Xie Y PLoS One; 2014; 9(1):e83819. PubMed ID: 24404139 [TBL] [Abstract][Full Text] [Related]
4. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator. Yu J; Ip E; Dela Peña A; Hou JY; Sesha J; Pera N; Hall P; Kirsch R; Leclercq I; Farrell GC Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554 [TBL] [Abstract][Full Text] [Related]
5. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. Wang Y; Ausman LM; Russell RM; Greenberg AS; Wang XD J Nutr; 2008 Oct; 138(10):1866-71. PubMed ID: 18806094 [TBL] [Abstract][Full Text] [Related]
6. Suppressing cyclooxygenase-2 prevents nonalcoholic and inhibits apoptosis of hepatocytes that are involved in the Akt/p53 signal pathway. Wu J; Chen C; Hu X; Cai X; Guan Y; Hu H; Wang Q; Chen X; Cai B; Jing X Biochem Biophys Res Commun; 2016 Jan; 469(4):1034-40. PubMed ID: 26723251 [TBL] [Abstract][Full Text] [Related]
7. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274 [TBL] [Abstract][Full Text] [Related]
8. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Csak T; Ganz M; Pespisa J; Kodys K; Dolganiuc A; Szabo G Hepatology; 2011 Jul; 54(1):133-44. PubMed ID: 21488066 [TBL] [Abstract][Full Text] [Related]
9. A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Svegliati-Baroni G; Candelaresi C; Saccomanno S; Ferretti G; Bachetti T; Marzioni M; De Minicis S; Nobili L; Salzano R; Omenetti A; Pacetti D; Sigmund S; Benedetti A; Casini A Am J Pathol; 2006 Sep; 169(3):846-60. PubMed ID: 16936261 [TBL] [Abstract][Full Text] [Related]
10. [Mechanism study of the protective effects of selective cyclooxygenase-2 enzyme inhibitors on the liver of rats with type 2 diabetes mellitus combined with nonalcoholic steatohepatitis via Rho/ROCK pathway]. Yuan L; Tian F Zhonghua Gan Zang Bing Za Zhi; 2022 Jan; 30(1):74-80. PubMed ID: 35152673 [No Abstract] [Full Text] [Related]
11. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. Gao Y; Song LX; Jiang MN; Ge GY; Jia YJ Inflammation; 2008 Apr; 31(2):121-32. PubMed ID: 18302012 [TBL] [Abstract][Full Text] [Related]
12. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664 [TBL] [Abstract][Full Text] [Related]
14. p38 MAPK signal pathway involved in anti-inflammatory effect of Chaihu-Shugan-San and Shen-ling-bai-zhu-San on hepatocyte in non-alcoholic steatohepatitis rats. Yang Q; Xu Y; Feng G; Hu C; Zhang Y; Cheng S; Wang Y; Gong X Afr J Tradit Complement Altern Med; 2014; 11(1):213-21. PubMed ID: 24653580 [TBL] [Abstract][Full Text] [Related]
15. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. Ren T; Zhu J; Zhu L; Cheng M Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426 [TBL] [Abstract][Full Text] [Related]
16. Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes. Wen SL; Gao JH; Yang WJ; Lu YY; Tong H; Huang ZY; Liu ZX; Tang CW J Gastroenterol Hepatol; 2014 Nov; 29(11):1932-42. PubMed ID: 24909904 [TBL] [Abstract][Full Text] [Related]
17. Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance. Jiang Y; Zhao M; An W J Mol Med (Berl); 2011 Dec; 89(12):1207-17. PubMed ID: 21814826 [TBL] [Abstract][Full Text] [Related]
18. Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Xu ZJ; Fan JG; Ding XD; Qiao L; Wang GL Dig Dis Sci; 2010 Apr; 55(4):931-40. PubMed ID: 19459046 [TBL] [Abstract][Full Text] [Related]